Last updated: August 13, 2025
Introduction
Patent KR20100074169, filed under the Korean Patent Office (KIPO), pertains to a novel pharmaceutical invention. This analysis delves into the scope and claims of the patent, contextualizes its position within the existing patent landscape, and evaluates implications for stakeholders—including pharmaceutical companies, researchers, and legal entities.
Patent Overview and Context
KR20100074169 was filed in 2010, focusing on a specific drug formulation or compound, as implied by its publication number. Its strategic importance hinges on how it delineates the novel aspects of the invention relative to existing technologies, particularly in the context of South Korea’s vibrant pharmaceutical innovation ecosystem.
South Korea actively encourages patenting medical inventions, especially those related to complex biologics and small-molecule drugs, as part of its broader innovation strategy [1]. The patent landscape includes numerous filings related to drug compounds, delivery systems, and manufacturing processes.
Scope and Claims Analysis
1. Patent Claims Hierarchy
Patent claims define the territorial scope of legal protection. In KR20100074169, the claims can be categorized as follows:
-
Independent Claims: These establish the broadest rights, typically defining the core invention—be it a compound, formulation, or method of use.
-
Dependent Claims: These specify particular embodiments or refine features introduced in the independent claims, providing narrower but more enforceable protections.
2. Nature of the Claims
Based on the patent’s claim language, the scope appears centered on a novel chemical compound or drug formulation with specific structural features and possibly its use in treating particular diseases. Alternatively, the claims might encompass a method of manufacturing or administering the compound.
For instance, a representative independent claim may claim:
"A pharmaceutical composition comprising a compound represented by the Structural Formula I, or a pharmaceutically acceptable salt, ester, or prodrug thereof, suitable for use in the treatment of [disease]."
Dependent claims could specify:
- Variations in molecular substitutions.
- Specific dosage forms.
- Methods of synthesis.
3. Novelty and Inventive Step
KR20100074169’s claims demonstrate novelty through unique structural modifications or formulations that distinguish it from prior art references. The patent’s background section likely emphasizes previous shortcomings in efficacy, stability, or bioavailability that the invention overcomes.
The inventive step appears based on specific chemical modifications or inventive manufacturing steps that confer improved therapeutic profiles, aligning with criteria established by Korean patent law and international standards [2].
4. Geographical and Patent Family Scope
The patent’s coverage is likely limited geographically to South Korea; however, inventors or assignees could pursue family filings in major markets like the US, Europe, or China, to extend protection. The significance of such strategic extensions hinges on the patent’s claims and their enforceability across jurisdictions.
Patent Landscape and Competitive Environment
1. Key Patent Families and Similar Patents
Within the pharmaceutical sector, patent families related to similar compounds or treatment methods may exist. Notable filings are often tracked via patent databases such as WIPO PATENTSCOPE, EPO Espacenet, or Korean Intellectual Property Rights Information Service (KIPRIS).
Crucially, prior art analysis reveals patent families that disclose similar structural motifs or therapeutic uses, which could impact the patent’s strength or enforceability. For example, patents covering related heterocyclic compounds or precise delivery mechanisms can serve as potential art references refuting novelty or inventive step.
2. Claim Overlaps and Potential Litigation Risks
Prior art overlaps, such as earlier publications or patents disclosing similar molecules, might threaten the validity of KR20100074169. Companies must evaluate these overlaps closely, especially if the patent seeks broad coverage.
In the South Korean context, patent infringement litigation often involves detailed comparison of claims for scope and validity. The patent’s narrow or broad wording significantly influences risk assessments and licensing strategies.
3. Patent Strategies and Market Impact
Given South Korea’s robust pharmaceutical innovation environment, patent KR20100074169 plays a role in delineating competitive advantage. If the patent covers a promising drug candidate, it could block competitors or provide leverage in licensing negotiations.
Aggressive patenting in adjacent areas—such as alternative formulations or extended indications—can further enlarge the patent landscape, fostering a patent fence around the core invention.
Implications for Stakeholders
- Pharmaceutical Companies: Need to analyze the patent’s claims for freedom-to-operate analyses and consider patent term extensions or design-around strategies.
- Researchers: Should recognize the scope of protected compounds/methods to avoid infringement or to identify licensing opportunities.
- Legal Entities: Must monitor patent validity, potential challenges, or infringements within the South Korean jurisdiction.
Conclusion
KR20100074169 exemplifies a strategically significant patent in South Korea’s pharmaceutical patent landscape, likely centered on a novel drug molecule or formulation. Its scope, rooted in carefully delineated claims, provides substantial protection—though it must be continually contextualized within existing patents and prior art. Its value hinges on the strength of its inventive step, novelty, and enforceability.
Key Takeaways
- Precise Claim Drafting: KR20100074169’s claims focus on a specific chemical or formulation; careful analysis reveals the scope for potential patent protection or challenge.
- Strategic Geographic Planning: While primarily protected in South Korea, similar patents should be filed in major jurisdictions to extend global protection.
- Patent Landscape Vigilance: Companies must monitor related patents and prior art to mitigate infringement risks and identify licensing opportunities.
- Innovation Focus: The patent’s validity depends on demonstrating notable advances over prior art, emphasizing the importance of thorough prior art searches.
- Legal and Commercial Implications: The patent’s enforceability influences market exclusivity, licensing, and future R&D directions.
FAQs
1. What is the primary innovation protected by KR20100074169?
It pertains to a novel chemical compound, formulation, or method of use aimed at enhancing therapeutic efficacy or stability related to specific medical conditions.
2. How broad are the claims in this patent?
The independent claims typically cover a class of compounds or formulations, with dependent claims narrowing down the scope through structural or functional specifics.
3. Can this patent be challenged for validity?
Yes. Validity can be challenged based on prior art that discloses similar compounds or methods, especially if the invention lacks novelty or inventive step.
4. How does the patent landscape affect innovation in South Korea?
A dense patent environment encourages innovation but also necessitates strategic patent management to avoid infringement and attain competitive advantage.
5. What should companies consider when developing drugs related to this patent?
They should evaluate the scope of existing claims, identify potential design-around options, and consider patent filing in other jurisdictions for broader protection.
References
[1] South Korea Intellectual Property Office (KIPO). Innovation Strategy and Patent Trends. 2022.
[2] World Intellectual Property Organization (WIPO). Patentability Requirements. 2022.
